Skip to main content
Premium Trial:

Request an Annual Quote

Genomic, Proteomic Research Will Be Focus of New UK Institute

NEW YORK (GenomeWeb News) — Genomic and proteomic technologies will play a role in a new University of Manchester institute that aims to promote interdisciplinary research.
 
The Manchester Interdisciplinary Biocenter will eventually oversee research projects from 80 sub-disciplines and house as many as 600 scientists.
 
The center said programs in biomolecular structure and dynamics and on technology and instrument development will focus on genomics and proteomics.
 
The Biocenter said it plans to perform research in mass spectrometry and its applications, such as metabolomics and secondary ion mass spectrometry. It has purchased a broad range of hardware for mass spec, SIMS, fluorescence spectroscopy, and single molecule technology.
 
The director of MIB said the goal is to “develop the systems that will allow us to understand how every gene in an organism works and reacts. … "

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.